Skip to main content

Posts

Showing posts with the label normal

Making use of the 'new normal' of wearable technology in clinical practice

Supply/Disclosures Supply: Ogdie A. Utilizing Private Technology to Observe and Enhance Outcomes in Inflammatory Arthritis. Introduced at: Interdisciplinary Autoimmune Summit; July 10-12, 2020 (digital assembly). Disclosures: Ogdie experiences consulting for AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Corrona, Janssen, Lilly, Novartis Prescription drugs, Pfizer, Takeda Pharmaceutical Firm and UCB; grant funding from Novartis Prescription drugs (to Penn), Pfizer (to Penn), Amgen (to Ahead/NDB); and royalties (to husband) from Novartis Prescription drugs. ADD TOPIC TO EMAIL ALERTS Obtain an e-mail when new articles are posted on Please present your e-mail handle to obtain an e-mail when new articles are posted on . Subscribe We have been unable to course of your request. Please strive